Roxiticus Valley Life Sciences Fund

RVLSF is a private equity investment fund with the investment objective of generating income and achieving significant capital appreciation from investments in a portfolio of high-growth companies. The Fund seeks to make investments primarily in privately held companies in rapidly growing market sectors of life sciences industries. Specific businesses in the sector including the Pharmaceutical, Specialty Pharmaceutical, Medical Devices, Biotechnology, Health Sciences, Healthcare Services, Healthcare Technologies, Nutrition and Diet and related industries will be candidates for investment.
 
The fund invests in seed, early stage, and expansion stage businesses especially those companies who can benefit from a strategic relationship with Roxiticus Ventures, a business management advisory, consulting and capital solutions development organization. RVF invests in companies with innovative approaches to solving industry problems or that have a competitive advantage in the market.

RVLSF Portfolio Companies

  • EKR Therapeutics, Inc.
  • Semprae Labs 
  • PNSI-Bright Foods 
  • ESP Pharma
  • Semprae Labs
  • CarpeVita, Inc.
  • ThoughtShift, Inc.
  • uCirrus Corp.


Roxiticus Valley Fund

The Roxiticus Valley Fund is a private equity venture capital fund that invests in early and expansion stage businesses in the Life Sciences, Business Technologies, Environmental Technologies, and Business Services Sectors. Our investment objective is generating income and achieving significant capital appreciation from investments in a portfolio of high-growth companies. The Roxiticus Valley Fund invests in a portfolio of emerging private companies in their start-up and early stages.
 

RVF Portfolio Companies

  • EKR Therapeutics, Inc.
  • PNSI-Bright Foods
  • ESP Pharma
  • Excelerant, Inc. 
  • emCrit, Inc.
  • CentreReach, Inc.